Biologics Contract Manufacturing Market Outlook Remains Highly Positive
The Global Biologics Contract Manufacturing Market size is expected to be worth around US$ 94.4 Billion by 2035 from US$ 35.4 Billion in 2025, growing at a CAGR of 10.3% during the forecast period 2026-2035. In 2025, North America led the market, achieving over 36.7% share with a revenue of US$ 13.0 Billion.